Roflumilast for asthma: Efficacy findings in mechanism of action studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Roflumilast for asthma: Efficacy findings in mechanism of action studies

Published:2015-12 Issue: Volume:35 Page:S4-S10
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Bardin P.,Kanniess F.,Gauvreau G.,Bredenbröker D.,Rabe K.F.

Funder

Caroline Loder of Synergy Vision

Takeda

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference22 articles.

1. Global strategy for asthma management and prevention. Global initiative for asthma (GINA),2014

2. Systemic effects of inhaled corticosteroids: an overview;Pandya;Open Respir. Med. J.,2014

3. Roflumilast for the treatment of COPD in an Asian population: a randomized, double-blind, parallel-group study;Zheng;Chest,2014

4. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials;Fabbri;Lancet,2009

5. Reduction of exacerbations by the PDE4 inhibitor roflumilast–the importance of defining different subsets of patients with COPD;Rennard;Respir. Res.,2011

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma Pathogenesis: Phenotypes, Therapies, and Gaps: Summary of the Aspen Lung Conference 2023;American Journal of Respiratory Cell and Molecular Biology;2024-08

2. The IL-4/13-induced production of M2 chemokines by human lung macrophages is enhanced by adenosine and PGE2;International Immunopharmacology;2024-02

3. Promising treatment biomarkers in asthma;Frontiers in Drug Safety and Regulation;2023-11-07

4. Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations;Journal of Asthma and Allergy;2023-09

5. Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary Disease;American Journal of Respiratory and Critical Care Medicine;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3